D. S. F. Ramadhan

Integrating AI-Based De Novo Design with Molecular Docking and Density Functional Theory Analysis to Optimize Flavonoid Scaffolds as p53-MDM2 Inhibitors for Triple-Negative Breast Cancer.

Computational Predicted Mechanism of Tiliroside Compound Against Triple-Negative Breast Cancer Using Network Pharmacology and Induced-Fit Docking Approach

Tiliroside exerts potential anti-TNBC activity through multitarget modulation of interconnected oncogenic signaling pathways, suggesting that tiliroside might be a promising lead compound for TNBC.